Dexcel Company Profile
What is the competitive landscape for DEXCEL
DEXCEL has fifteen approved drugs.
There are seven US patents protecting DEXCEL drugs. There is one tentative approval on DEXCEL drugs.
Summary for Dexcel
| US Patents: | 7 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 15 |
| Patent Litigation for Dexcel: | See patent lawsuits for Dexcel |
Drugs and US Patents for Dexcel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dexcel Ltd | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 210822-001 | Aug 29, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dexcel | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 214278-001 | Oct 20, 2020 | DISCN | Yes | No | 10,835,488 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Dexcel Ltd | DICLOFENAC SODIUM | diclofenac sodium | TABLET, EXTENDED RELEASE;ORAL | 076201-001 | Nov 6, 2002 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Dexcel | NINTEDANIB ESYLATE | nintedanib esylate | CAPSULE;ORAL | 219819-002 | Apr 2, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dexcel | LANSOPRAZOLE | lansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208025-001 | Jun 7, 2016 | OTC | No | No | 11,986,554 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Dexcel | HEMADY | dexamethasone | TABLET;ORAL | 211379-001 | Oct 3, 2019 | RX | Yes | Yes | 10,537,585 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dexcel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dexcel Pharma | OMEPRAZOLE | omeprazole | TABLET, DELAYED RELEASE;ORAL | 022032-001 | Dec 4, 2007 | 9,023,391 | ⤷ Start Trial |
| Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | 5,023,082 | ⤷ Start Trial |
| Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | 5,002,769 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for DEXCEL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Dexcel Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 208925 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2019123453 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016174664 | ⤷ Start Trial |
| European Patent Office | 3471708 | ⤷ Start Trial |
| European Patent Office | 3288556 | ⤷ Start Trial |
| European Patent Office | 2293782 | ⤷ Start Trial |
| European Patent Office | 3932396 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dexcel Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1830843 | CR 2015 00036 | Denmark | ⤷ Start Trial | PRODUCT NAME: NINTEDANIB ELLER EN TAUTOMER, BLANDINGERNE DERAF ELLER ET SALT DERAF, SAERLIGT NINTEDANIB ESILAT; REG. NO/DATE: EU/1/14/979/001-004 20150119 |
| 1581193 | SPC/GB12/047 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727 |
| 0984957 | 2012/048 | Ireland | ⤷ Start Trial | PRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812 |
| 1830843 | 92762 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: NINTEDANIB , OU UN TAUTOMERE, LES MELANGES OBTENUS OU UN DESES SELS, EN PARTICULIER NINTEDANIB ESILATE. FIRST REGISTRATION: 20150119 |
| 1224170 | C300725 | Netherlands | ⤷ Start Trial | PRODUCT NAME: NINTEDANIB, DE TAUTOMEREN DAARVAN EN DE ZOUTEN DAARVAN, IN HET BIJZONDER NINTEDANIB EN FYSIOLOGISCH AANVAARDBARE ZOUTEN DAARVAN, MET NAME NINEDANIBESILAAT; REGISTRATION NO/DATE: EU/1/14/954/001-004 20141121 |
| 1224170 | PA2015015 | Lithuania | ⤷ Start Trial | PRODUCT NAME: NINTEDANIBUM; REGISTRATION NO/DATE: EU/1/14/954/001-004 20141121 |
| 1224170 | 17/2015 | Austria | ⤷ Start Trial | PRODUCT NAME: NINTEDANIB UND DESSEN PHYSIOLOGISCH VERTRAEGLICHE SALZE, INSBESONDERE NINTEDANIB ESILAT; REGISTRATION NO/DATE: EU/1/14/954 (MITTEILUNG) 20141125 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
